📰 Regarding Use News
Page 13 - Regarding Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Regarding Use. Real-time updates on events, politics, business and more.
December 19, 2022
During an open meeting held December 14, 2022, the SEC voted unanimously in favor of adopting changes to the rules governing insider trading defenses, including amendments to Rule...
December 6, 2022
-- Recorded Second Quarter Revenue of $34.8 Million -- -- Signed $26 Million in Net New Business Orders Resulting in a Backlog of $147 Million, an Increase of 23% Year-Over-Year -- -- Mammalian... | December 6, 2022
November 15, 2022
RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine
November 14, 2022
Prescription product net revenue of approximately $3.1 million in Q3 2022 increased 8.2% over Q2 2022 and increased approximately 412% over prescription product net revenue in Q3 2021Core initiatives:OnTarget
November 10, 2022
10.11.2022 - Steel Partners Holdings L.P. (NYSE: SPLP), a diversified global holding company, today announced operating results for the third quarter ended September 30, 2022. Q3 2022 Q3 2021 ($ in thousands) YTD 2022 YTD 2021 $425,673 $392,113 ...
November 9, 2022
08.11.2022 - Performant Financial Corporation (Nasdaq: PFMT), (the Company), a leading provider of technology-enabled audit, recovery, and related analytics services in the United States with a focus in the healthcare payment integrity services industry, today ...
November 8, 2022
/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today reported its financial and operating results for the third quarter ended...
November 8, 2022
DENVER, Nov. 08, 2022 -- InnovAge Holding Corp. , a market leading healthcare delivery platform for high-cost, dual-eligible seniors, announced financial results for its fiscal first quarter ended... | November 8, 2022
November 7, 2022
ITEM 2. Managements Discussion and Analysis of Financial Condition and Results of Operations The Companys Condensed Consolidated Statements of Operations for the three month and nine months ended... | November 7, 2022
November 3, 2022
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the third quarter ended September 30, 2022. Key h...